To validate the zebrafish as a potential in vivo pre-clinical model, we xenotransplanted different human cells, including cancer cells and normal human primary cells (CD34+ HSPC and CD3+ T-cells; Fig. 2B,C). This evidence concerns the gene CD34 and cancer.